digital therapeutics

News

Despite US turmoil, Hinge Health pushes ahead with IPO

Digital health firm Hinge has published a new prospectus for its IPO, shrugging off the weakness in US stock markets caused by Trump's tariffs.

News

FDA clears first migraine DTx from Click Therapeutics

Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the FDA, becoming the first treatment of its type in the US.

Patients

Reuters pharmaUS 25 Brian Hilberdink Feature

New Boehringer US Head Brian Hilberdink talks GLP-1s, DTx an...

At Reuters Pharma USA, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US human pharma at Boehringer Ingelheim.

News

Digital health firm XRHealth hits the M&A trial again

XRHealth has made its second acquisition in the space of a few months, buying digital therapeutics (DTx) company RealizedCare.

News

Kyorin partners Hyfe to develop DTx for chronic cough

Kyorin Pharma has signed a deal with Hyfe to develop a digital therapeutic (DTx) for people with chronic cough and launch it in Japan.

News

Shionogi gets approval in Japan for ADHD digital therapeutic

Shionogi will market the EndeavorRide app, originally licensed from Akili, in Japan following its approval by the MHLW regulator.

Despite US turmoil, Hinge Health pushes ahead with IPO

FDA clears first migraine DTx from Click Therapeutics

New Boehringer US Head Brian Hilberdink talks GLP-1s, DTx an...

Digital health firm XRHealth hits the M&A trial again

Kyorin partners Hyfe to develop DTx for chronic cough

Shionogi gets approval in Japan for ADHD digital therapeutic

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

digital therapeutics

Editor's Picks